Literature DB >> 15309683

Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.

Yoshihiro Kokubo1, Kei Kamide2, Nozomu Inamoto3, Chihiro Tanaka4, Mariko Banno4, Shin Takiuchi2, Yuhei Kawano2, Hitonobu Tomoike3, Toshiyuki Miyata4.   

Abstract

The deletion of thiazide-sensitive Na-Cl cotransporter ( TSC, SLC12A3) causes Gitelman's syndrome characterized by low blood pressure, while deletions of the WNK1 ( PRKWNK1) and WNK4 ( PRKWNK4) genes cause familial hypertension known as pseudohypoaldosteronism type II. Recent studies have revealed that cell surface expression of TSC is regulated by WNK1 and WNK4. We hypothesized that molecular variations in TSC, WNK1, and WNK4 could lead to an increased morbidity of hypertension. We identified 52, 35, and 21 polymorphisms in Japanese hypertensives by sequencing the entire coding regions of TSC, WNK1 and WNK4, respectively. Twenty-one representative polymorphisms were genotyped in 1,818 Japanese individuals (771 subjects with hypertension and 1,047 controls) randomly sampled in Suita city. The results indicated that the systolic blood pressure in men with the CT+TT genotype in WNK4 C14717T was 3.1 mmHg higher than those with the CC genotype ( p=0.042) after adjustment with confounding factors such as age, BMI, hyperlipidemia, diabetes mellitus, antihypertensive drug use, smoking, and drinking. Multivariate logistic regression analysis (with adjustment for the same parameters) in men revealed that the odds ratio for the presence of hypertension of the CT+TT genotype in C14717T to the CC genotype was 1.62 ( p=0.010, 95% confidence interval, 1.12-2.33). Association of TSC and WNK1 with hypertension was not observed. In conclusion, our study suggests the possible involvement of WNK4 in essential hypertension in a Japanese general population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309683     DOI: 10.1007/s10038-004-0181-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes.

Authors:  Tomohiko Okuda; Yoshihiko Fujioka; Kei Kamide; Yuhei Kawano; Yoichi Goto; Yasunao Yoshimasa; Hitonobu Tomoike; Naoharu Iwai; Sotaro Hanai; Toshiyuki Miyata
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

2.  Genetic variants of WNK4 in whites and African Americans with hypertension.

Authors:  Porat M Erlich; Jing Cui; Irmarie Chazaro; Lindsay A Farrer; Clinton T Baldwin; Haralambos Gavras; Anita L DeStefano
Journal:  Hypertension       Date:  2003-04-28       Impact factor: 10.190

3.  An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms.

Authors:  Chihiro Tanaka; Kei Kamide; Shin Takiuchi; Yoshikazu Miwa; Masayoshi Yoshii; Yuhei Kawano; Toshiyuki Miyata
Journal:  Hypertens Res       Date:  2003-04       Impact factor: 3.872

4.  Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes.

Authors:  Kei Kamide; Shin Takiuchi; Chihiro Tanaka; Yoshikazu Miwa; Masayoshi Yoshii; Takeshi Horio; Toshifumi Mannami; Yoshihiro Kokubo; Hitonobu Tomoike; Yuhei Kawano; Toshiyuki Miyata
Journal:  Am J Hypertens       Date:  2004-05       Impact factor: 2.689

5.  Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat.

Authors:  H J Jacob; K Lindpaintner; S E Lincoln; K Kusumi; R K Bunker; Y P Mao; D Ganten; V J Dzau; E S Lander
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.

Authors:  D B Simon; C Nelson-Williams; M J Bia; D Ellison; F E Karet; A M Molina; I Vaara; F Iwata; H M Cushner; M Koolen; F J Gainza; H J Gitleman; R P Lifton
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

7.  WNK4 intron 10 polymorphism is not associated with hypertension.

Authors:  Helen J L Speirs; Brian J Morris
Journal:  Hypertension       Date:  2004-02-16       Impact factor: 10.190

8.  Identification of 21 single nucleotide polymorphisms in human hepatocyte growth factor gene and association with blood pressure and carotid atherosclerosis in the Japanese population.

Authors:  Shin Takiuchi; Toshifumi Mannami; Toshiyuki Miyata; Kei Kamide; Chihiro Tanaka; Yoshihiro Kokubo; Yuko Koyama; Nozomu Inamoto; Tomohiro Katsuya; Naoharu Iwai; Yuhei Kawano; Toshio Ogihara; Hitonobu Tomoike
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

9.  Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension.

Authors:  A V Benjafield; K Katyk; B J Morris
Journal:  Clin Genet       Date:  2003-11       Impact factor: 4.438

10.  Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome.

Authors:  N Mastroianni; A Bettinelli; M Bianchetti; G Colussi; M De Fusco; F Sereni; A Ballabio; G Casari
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

View more
  11 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population.

Authors:  Rina Kimura; Yoshihiro Kokubo; Kotaro Miyashita; Ryoichi Otsubo; Kazuyuki Nagatsuka; Toshiho Otsuki; Toshiyuki Sakata; Junko Nagura; Akira Okayama; Kazuo Minematsu; Hiroaki Naritomi; Shigenori Honda; Kiyoshi Sato; Hitonobu Tomoike; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 3.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Tag polymorphisms of solute carrier family 12 member 3 gene modify the risk of hypertension in northeastern Han Chinese.

Authors:  Y L Wang; Y Qi; J N Bai; Z M Qi; J R Li; H Y Zhao; Y F Wang; C Z Lu; Y Xiao; N Jia; B Wang; W Q Niu
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

5.  Association of Ala589Ser polymorphism of WNK4 gene with essential hypertension in a high-risk Chinese population.

Authors:  Zhi-Jun Sun; Yan Li; Jing-Yu Lu; Qian Ding; Yu Liang; Jing-Pu Shi; Jesse Li-Ling; Yan-Yan Zhao
Journal:  J Physiol Sci       Date:  2008-12-17       Impact factor: 2.781

Review 6.  Hypertension: the missing WNKs.

Authors:  Hashem A Dbouk; Chou-Long Huang; Melanie H Cobb
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-23

7.  Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans.

Authors:  Margus Putku; Katrin Kepp; Elin Org; Siim Sõber; David Comas; Margus Viigimaa; Gudrun Veldre; Peeter Juhanson; Pille Hallast; Neeme Tõnisson; Sue Shaw-Hawkins; Mark J Caulfield; Elza Khusnutdinova; Viktor Kožich; Patricia B Munroe; Maris Laan
Journal:  Hum Mutat       Date:  2011-05-10       Impact factor: 4.878

8.  Principles in genetic risk assessment.

Authors:  Pedro Viana Baptista
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

9.  Lack of family-based association between common variations in WNK1 and blood pressure level.

Authors:  Fuqiang Liu; Qiufang Lian; Jie Ren; Keyu Ren; Yang Wang; Dan Wang; Chao Chu; Lan Wang; Tongshuai Guo; Enqi Liu; Jianjun Mu; Zuyi Yuan
Journal:  Med Sci Monit       Date:  2014-10-16

10.  Novel Association of WNK4 Gene, Ala589Ser Polymorphism in Essential Hypertension, and Type 2 Diabetes Mellitus in Malaysia.

Authors:  Nooshin Ghodsian; Patimah Ismail; Salma Ahmadloo; Farzad Heidari; Polin Haghvirdizadeh; Sima Ataollahi Eshkoor; Ali Etemad
Journal:  J Diabetes Res       Date:  2016-05-29       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.